Immuneed Company
Immuneed is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system.
Founded Date:
2014
Last Funding Type:
Seed
Headquarters:
Uppsala, Uppsala Lan, Sweden
Technology:
Cancer
Employee Number:
11-50
Industry:
PharmTech
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Total Funding:
$1.3M